331 related articles for article (PubMed ID: 26041736)
21. Indoleamine 2,3-dioxygenase-expressing dendritic cells are involved in the generation of CD4+CD25+ regulatory T cells in Peyer's patches in an orally tolerized, collagen-induced arthritis mouse model.
Park MJ; Min SY; Park KS; Cho YG; Cho ML; Jung YO; Park HS; Chang SH; Cho SG; Min JK; Park SH; Kim HY
Arthritis Res Ther; 2008; 10(1):R11. PubMed ID: 18221522
[TBL] [Abstract][Full Text] [Related]
22. Suppression of acute graft-versus-host response by TCDD is independent of the CTLA-4-IFN-γ-IDO pathway.
Rohlman D; Punj S; Pennington J; Bradford S; Kerkvliet NI
Toxicol Sci; 2013 Sep; 135(1):81-90. PubMed ID: 23798565
[TBL] [Abstract][Full Text] [Related]
23. Activation of p38 mitogen-activated protein kinase drives dendritic cells to become tolerogenic in ret transgenic mice spontaneously developing melanoma.
Zhao F; Falk C; Osen W; Kato M; Schadendorf D; Umansky V
Clin Cancer Res; 2009 Jul; 15(13):4382-90. PubMed ID: 19549770
[TBL] [Abstract][Full Text] [Related]
24. Wnt5a signaling increases IL-12 secretion by human dendritic cells and enhances IFN-γ production by CD4+ T cells.
Valencia J; Martínez VG; Hidalgo L; Hernández-López C; Canseco NM; Vicente A; Varas A; Sacedón R
Immunol Lett; 2014 Nov; 162(1 Pt A):188-99. PubMed ID: 25196330
[TBL] [Abstract][Full Text] [Related]
25. Variable indoleamine 2,3-dioxygenase expression in acral/mucosal melanoma and its possible link to immunotherapy.
Iga N; Otsuka A; Hirata M; Kataoka TR; Irie H; Nakashima C; Matsushita S; Uchi H; Yamamoto Y; Funakoshi T; Fujisawa Y; Yoshino K; Fujimura T; Hata H; Ishida Y; Kabashima K
Cancer Sci; 2019 Nov; 110(11):3434-3441. PubMed ID: 31509303
[TBL] [Abstract][Full Text] [Related]
26. A new cancer immunotherapy via simultaneous DC-mobilization and DC-targeted IDO gene silencing using an immune-stimulatory nanosystem.
Zhang Y; Fu J; Shi Y; Peng S; Cai Y; Zhan X; Song N; Liu Y; Wang Z; Yu Y; Wang Y; Shi Q; Fu Y; Yuan K; Zhou N; Joshi R; Ichim TE; Min W
Int J Cancer; 2018 Oct; 143(8):2039-2052. PubMed ID: 29752722
[TBL] [Abstract][Full Text] [Related]
27. Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase.
Muller AJ; Sharma MD; Chandler PR; Duhadaway JB; Everhart ME; Johnson BA; Kahler DJ; Pihkala J; Soler AP; Munn DH; Prendergast GC; Mellor AL
Proc Natl Acad Sci U S A; 2008 Nov; 105(44):17073-8. PubMed ID: 18952840
[TBL] [Abstract][Full Text] [Related]
28. From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past.
Shadbad MA; Hajiasgharzadeh K; Derakhshani A; Silvestris N; Baghbanzadeh A; Racanelli V; Baradaran B
Front Immunol; 2021; 12():623639. PubMed ID: 33692796
[TBL] [Abstract][Full Text] [Related]
29. Prolongation of kidney allograft survival regulated by indoleamine 2, 3-dioxygenase in immature dendritic cells generated from recipient type bone marrow progenitors.
Na N; Luo Y; Zhao D; Yang S; Hong L; Li H; Miao B; Qiu J
Mol Immunol; 2016 Nov; 79():22-31. PubMed ID: 27689750
[TBL] [Abstract][Full Text] [Related]
30. Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?
Chevolet I; Speeckaert R; Haspeslagh M; Neyns B; Krüse V; Schreuer M; Van Gele M; Van Geel N; Brochez L
Br J Dermatol; 2014 Nov; 171(5):987-95. PubMed ID: 24814041
[TBL] [Abstract][Full Text] [Related]
31. The role of FoxP3+ regulatory T cells and IDO+ immune and tumor cells in malignant melanoma - an immunohistochemical study.
Salmi S; Lin A; Hirschovits-Gerz B; Valkonen M; Aaltonen N; Sironen R; Siiskonen H; Pasonen-Seppänen S
BMC Cancer; 2021 May; 21(1):641. PubMed ID: 34051744
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic effect of exosomes from indoleamine 2,3-dioxygenase-positive dendritic cells in collagen-induced arthritis and delayed-type hypersensitivity disease models.
Bianco NR; Kim SH; Ruffner MA; Robbins PD
Arthritis Rheum; 2009 Feb; 60(2):380-9. PubMed ID: 19180475
[TBL] [Abstract][Full Text] [Related]
33. A distinct tolerogenic subset of splenic IDO(+)CD11b(+) dendritic cells from orally tolerized mice is responsible for induction of systemic immune tolerance and suppression of collagen-induced arthritis.
Park MJ; Park KS; Park HS; Cho ML; Hwang SY; Min SY; Park MK; Park SH; Kim HY
Cell Immunol; 2012; 278(1-2):45-54. PubMed ID: 23121975
[TBL] [Abstract][Full Text] [Related]
34. Immune suppression and resistance mediated by constitutive activation of Wnt/β-catenin signaling in human melanoma cells.
Yaguchi T; Goto Y; Kido K; Mochimaru H; Sakurai T; Tsukamoto N; Kudo-Saito C; Fujita T; Sumimoto H; Kawakami Y
J Immunol; 2012 Sep; 189(5):2110-7. PubMed ID: 22815287
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity.
Sharma MD; Pacholczyk R; Shi H; Berrong ZJ; Zakharia Y; Greco A; Chang CS; Eathiraj S; Kennedy E; Cash T; Bollag RJ; Kolhe R; Sadek R; McGaha TL; Rodriguez P; Mandula J; Blazar BR; Johnson TS; Munn DH
Immunity; 2021 Oct; 54(10):2354-2371.e8. PubMed ID: 34614413
[TBL] [Abstract][Full Text] [Related]
36. Decreased indoleamine 2,3-dioxygenase expression in dendritic cells and role of indoleamine 2,3-dioxygenase-expressing dendritic cells in immune thrombocytopenia.
Xu SQ; Wang CY; Zhu XJ; Dong XY; Shi Y; Peng J; Qin P; Sun JZ; Guo C; Ni H; Hou M
Ann Hematol; 2012 Oct; 91(10):1623-31. PubMed ID: 22526360
[TBL] [Abstract][Full Text] [Related]
37. Indoleamine 2,3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes.
Sharma MD; Hou DY; Liu Y; Koni PA; Metz R; Chandler P; Mellor AL; He Y; Munn DH
Blood; 2009 Jun; 113(24):6102-11. PubMed ID: 19366986
[TBL] [Abstract][Full Text] [Related]
38. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
39. STING Promotes the Growth of Tumors Characterized by Low Antigenicity via IDO Activation.
Lemos H; Mohamed E; Huang L; Ou R; Pacholczyk G; Arbab AS; Munn D; Mellor AL
Cancer Res; 2016 Apr; 76(8):2076-81. PubMed ID: 26964621
[TBL] [Abstract][Full Text] [Related]
40. Glycogen Synthase Kinase-3β (GSK-3β) Inhibition Enhances Dendritic Cell-based Cancer Vaccine Potency via Suppression of Interferon-γ-induced Indoleamine 2,3-Dioxygenase Expression.
Noh KT; Son KH; Jung ID; Kang TH; Choi CH; Park YM
J Biol Chem; 2015 May; 290(19):12394-402. PubMed ID: 25814664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
